| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:1902751 | BP | positive regulation of cell cycle G2/M phase transition | Any process that activates or increases the frequency, rate or extent of cell cycle G2/M phase transition. |
NPM1 |
GO:1902766 | BP | skeletal muscle satellite cell migration | The orderly movement of a skeletal muscle satellite cell from one site to another. Migration of these cells is a key step in the process of growth and repair of skeletal muscle cells. |
RHOA |
GO:1902771 | BP | positive regulation of choline O-acetyltransferase activity | Any process that activates or increases the frequency, rate or extent of choline O-acetyltransferase activity. |
SORL1 |
GO:1902774 | BP | late endosome to lysosome transport | The directed movement of substances from late endosome to lysosome. |
SNAPIN |
GO:1902775 | BP | mitochondrial large ribosomal subunit assembly | The aggregation, arrangement and bonding together of a set of components to form a mitochondrial large ribosomal subunit. |
DHX30, DDX28 |
GO:1902803 | BP | regulation of synaptic vesicle transport | Any process that modulates the frequency, rate or extent of synaptic vesicle transport. |
PARK2, PINK1 |
GO:1902806 | BP | regulation of cell cycle G1/S phase transition | Any process that modulates the frequency, rate or extent of cell cycle G1/S phase transition. |
ATP2B4 |
GO:1902808 | BP | positive regulation of cell cycle G1/S phase transition | Any process that activates or increases the frequency, rate or extent of cell cycle G1/S phase transition. |
PHB2, PAGR1, FAM83D |
GO:1902809 | BP | regulation of skeletal muscle fiber differentiation | Any process that modulates the frequency, rate or extent of skeletal muscle fiber differentiation. |
NLN |
GO:1902823 | BP | negative regulation of late endosome to lysosome transport | Any process that stops, prevents or reduces the frequency, rate or extent of late endosome to lysosome transport. |
VPS35 |
GO:1902824 | BP | positive regulation of late endosome to lysosome transport | Any process that activates or increases the frequency, rate or extent of late endosome to lysosome transport. |
SNAPIN, ARF1 |
GO:1902828 | BP | positive regulation of L-arginine import into cell | Any process that activates or increases the frequency, rate or extent of L-arginine import into cell. |
AGT |
GO:1902847 | BP | regulation of neuronal signal transduction | Any process that modulates the frequency, rate or extent of neuronal signal transduction. |
CLU |
GO:1902850 | BP | microtubule cytoskeleton organization involved in mitosis | Any microtubule cytoskeleton organization that is involved in mitosis. |
TACC3 |
GO:1902856 | BP | negative regulation of nonmotile primary cilium assembly | Any process that stops, prevents or reduces the frequency, rate or extent of nonmotile primary cilium assembly. |
MAK |
GO:1902857 | BP | positive regulation of nonmotile primary cilium assembly | Any process that activates or increases the frequency, rate or extent of nonmotile primary cilium assembly. |
SEPT7, CEP135, CENPJ, WRAP73 |
GO:1902861 | BP | copper ion import into cell | The directed movement of copper ions from outside of a cell into the cytoplasmic compartment. This may occur via transport across the plasma membrane or via endocytosis. |
SLC31A1 |
GO:1902884 | BP | positive regulation of response to oxidative stress | Any process that activates or increases the frequency, rate or extent of response to oxidative stress. |
SEPN1 |
GO:1902891 | BP | negative regulation of root hair elongation | Any process that stops, prevents or reduces the frequency, rate or extent of root hair elongation. |
GAL |
GO:1902894 | BP | negative regulation of pri-miRNA transcription from RNA polymerase II promoter | Any process that stops, prevents or reduces the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter. |
NFIB, PDGFB, SOX9, PPARD, PPARA, NFATC4 |
GO:1902895 | BP | positive regulation of pri-miRNA transcription from RNA polymerase II promoter | Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter. |
SMAD6, FOS, PDGFB, TGFB1, JUN, NGFR, BMP2, BMP4, BMPR1A, STAT3, SMARCA4, SMAD3, RELA, SMAD1, HIF1A, GNL3 |
GO:1902896 | BP | terminal web assembly | The aggregation, arrangement and bonding together of a set of components to form a terminal web. |
EZR, PLS1 |
GO:1902897 | BP | regulation of postsynaptic density protein 95 clustering | Any process that modulates the frequency, rate or extent of postsynaptic density protein 95 clustering. |
CDH2, CRIPT |
GO:1902902 | BP | negative regulation of autophagosome assembly | Any process that stops, prevents or reduces the frequency, rate or extent of autophagosome assembly. |
MTM1, FEZ1, PINK1, CHMP4B |
GO:1902905 | BP | positive regulation of fibril organization | Any process that activates or increases the frequency, rate or extent of fibril organization. |
GPX1 |
GO:1902916 | BP | positive regulation of protein polyubiquitination | Any process that activates or increases the frequency, rate or extent of protein polyubiquitination. |
SKP2 |
GO:1902943 | BP | positive regulation of voltage-gated chloride channel activity | Any process that activates or increases the frequency, rate or extent of voltage-gated chloride channel activity. |
CFTR, PTAFR |
GO:1902946 | BP | protein localization to early endosome | A process in which a protein is transported to, or maintained in, a location within an early endosome. |
NRP1 |
GO:1902947 | BP | regulation of tau-protein kinase activity | Any process that modulates the frequency, rate or extent of tau-protein kinase activity. |
HGF |
GO:1902948 | BP | negative regulation of tau-protein kinase activity | Any process that stops, prevents or reduces the frequency, rate or extent of tau-protein kinase activity. |
SORL1 |
GO:1902949 | BP | positive regulation of tau-protein kinase activity | Any process that activates or increases the frequency, rate or extent of tau-protein kinase activity. |
CLU |
GO:1902952 | BP | positive regulation of dendritic spine maintenance | Any process that activates or increases the frequency, rate or extent of dendritic spine maintenance. |
APOE |
GO:1902953 | BP | positive regulation of ER to Golgi vesicle-mediated transport | Any process that activates or increases the frequency, rate or extent of ER to Golgi vesicle-mediated transport. |
ARF1, SORL1 |
GO:1902955 | BP | positive regulation of early endosome to recycling endosome transport | Any process that activates or increases the frequency, rate or extent of early endosome to recycling endosome transport. |
SORL1 |
GO:1902957 | BP | negative regulation of mitochondrial electron transport, NADH to ubiquinone | Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone. |
SNCA, DNAJC15 |
GO:1902958 | BP | positive regulation of mitochondrial electron transport, NADH to ubiquinone | Any process that activates or increases the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone. |
PINK1 |
GO:1902959 | BP | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | Any process that modulates the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process. |
PICALM |
GO:1902960 | BP | negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | Any process that stops, prevents or reduces the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process. |
SORL1 |
GO:1902961 | BP | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | Any process that activates or increases the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process. |
PICALM |
GO:1902963 | BP | negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process | Any process that stops, prevents or reduces the frequency, rate or extent of metalloendopeptidase activity involved in amyloid precursor protein catabolic process. |
PICALM, SORL1 |
GO:1902966 | BP | positive regulation of protein localization to early endosome | Any process that activates or increases the frequency, rate or extent of protein localization to early endosome. |
EZR, RDX, SORL1 |
GO:1902975 | BP | mitotic DNA replication initiation | Any DNA replication initiation involved in mitotic cell cycle DNA replication. |
GINS2 |
GO:1902979 | BP | mitotic DNA replication termination | Any DNA replication termination involved in mitotic cell cycle DNA replication. |
RTFDC1 |
GO:1902983 | BP | DNA strand elongation involved in mitotic DNA replication | Any DNA strand elongation involved in mitotic cell cycle DNA replication. |
GINS1 |
GO:1902990 | BP | mitotic telomere maintenance via semi-conservative replication | Any telomere maintenance via semi-conservative replication that is involved in mitotic cell cycle. |
PCNA, DNA2 |
GO:1902995 | BP | positive regulation of phospholipid efflux | Any process that activates or increases the frequency, rate or extent of phospholipid efflux. |
APOE |
GO:1902997 | BP | negative regulation of neurofibrillary tangle assembly | Any process that stops, prevents or reduces the frequency, rate or extent of neurofibrillary tangle assembly. |
SORL1 |
GO:1902998 | BP | positive regulation of neurofibrillary tangle assembly | Any process that activates or increases the frequency, rate or extent of neurofibrillary tangle assembly. |
CLU |
GO:1903002 | BP | positive regulation of lipid transport across blood brain barrier | Any process that activates or increases the frequency, rate or extent of lipid transport across blood brain barrier. |
APOE |
GO:1903003 | BP | positive regulation of protein deubiquitination | Any process that activates or increases the frequency, rate or extent of protein deubiquitination. |
TANK |
GO:1903006 | BP | positive regulation of protein K63-linked deubiquitination | Any process that activates or increases the frequency, rate or extent of protein K63-linked deubiquitination. |
VCP |
GO:1903007 | BP | positive regulation of Lys63-specific deubiquitinase activity | Any process that activates or increases the frequency, rate or extent of Lys63-specific deubiquitinase activity. |
VCP |
GO:1903010 | BP | regulation of bone development | Any process that modulates the frequency, rate or extent of bone development. |
GLI3 |
GO:1903011 | BP | negative regulation of bone development | Any process that stops, prevents or reduces the frequency, rate or extent of bone development. |
RGN |
GO:1903016 | BP | negative regulation of exo-alpha-sialidase activity | Any process that stops, prevents or reduces the frequency, rate or extent of exo-alpha-sialidase activity. |
APCS, PTX3 |
GO:1903019 | BP | negative regulation of glycoprotein metabolic process | Any process that stops, prevents or reduces the frequency, rate or extent of glycoprotein metabolic process. |
APCS, PTX3 |
GO:1903020 | BP | positive regulation of glycoprotein metabolic process | Any process that activates or increases the frequency, rate or extent of glycoprotein metabolic process. |
RAB1A, RAB1B |
GO:1903025 | BP | regulation of RNA polymerase II regulatory region sequence-specific DNA binding | Any process that modulates the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding. |
LIF |
GO:1903026 | BP | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding | Any process that stops, prevents or reduces the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding. |
DDIT3, ID1 |
GO:1903033 | BP | positive regulation of microtubule plus-end binding | Any process that activates or increases the frequency, rate or extent of microtubule plus-end binding. |
MAPRE1, MAPRE3 |
GO:1903034 | BP | regulation of response to wounding | Any process that modulates the frequency, rate or extent of response to wounding. |
IL10 |
GO:1903038 | BP | negative regulation of leukocyte cell-cell adhesion | Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte cell-cell adhesion. |
ASS1, PPARA |
GO:1903044 | BP | protein localization to membrane raft | A process in which a protein is transported to, or maintained in, a location within a membrane raft. |
FLOT1, RFTN1 |
GO:1903045 | BP | neural crest cell migration involved in sympathetic nervous system development | Any neural crest cell migration that is involved in sympathetic nervous system development. |
SEMA3A |
GO:1903047 | BP | mitotic cell cycle process | A process that is part of the mitotic cell cycle. |
KIF14 |
GO:1903052 | BP | positive regulation of proteolysis involved in cellular protein catabolic process | Any process that activates or increases the frequency, rate or extent of proteolysis involved in cellular protein catabolic process. |
CTSC, RGN |
GO:1903053 | BP | regulation of extracellular matrix organization | Any process that modulates the frequency, rate or extent of extracellular matrix organization. |
TCF15 |
GO:1903056 | BP | regulation of melanosome organization | Any process that modulates the frequency, rate or extent of melanosome organization. |
ZEB2 |
GO:1903061 | BP | positive regulation of protein lipidation | Any process that activates or increases the frequency, rate or extent of protein lipidation. |
RAB3GAP1, SVIP, RAB3GAP2 |
GO:1903070 | BP | negative regulation of ER-associated ubiquitin-dependent protein catabolic process | Any process that stops, prevents or reduces the frequency, rate or extent of ER-associated ubiquitin-dependent protein catabolic process. |
SVIP |
GO:1903071 | BP | positive regulation of ER-associated ubiquitin-dependent protein catabolic process | Any process that activates or increases the frequency, rate or extent of ER-associated ubiquitin-dependent protein catabolic process. |
SGTA, BCAP31, CAV1 |
GO:1903076 | BP | regulation of protein localization to plasma membrane | Any process that modulates the frequency, rate or extent of protein localization to plasma membrane. |
STX7, GBP1, SPTBN1, VTI1B |
GO:1903077 | BP | negative regulation of protein localization to plasma membrane | Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane. |
TGFB1, GBP1, NUMB, DAB2, AP2M1 |
GO:1903078 | BP | positive regulation of protein localization to plasma membrane | Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane. |
SPTBN1, STX4, STX3 |
GO:1903126 | BP | negative regulation of centriole-centriole cohesion | Any process that stops, prevents or reduces the frequency, rate or extent of centriole-centriole cohesion. |
NEK2 |
GO:1903140 | BP | regulation of establishment of endothelial barrier | Any process that modulates the frequency, rate or extent of establishment of endothelial barrier. |
ROCK2, TNF, IL1B |
GO:1903141 | BP | negative regulation of establishment of endothelial barrier | Any process that stops, prevents or reduces the frequency, rate or extent of establishment of endothelial barrier. |
S1PR3 |
GO:1903142 | BP | positive regulation of establishment of endothelial barrier | Any process that activates or increases the frequency, rate or extent of establishment of endothelial barrier. |
CDH5 |
GO:1903146 | BP | regulation of mitophagy | Any process that modulates the frequency, rate or extent of mitochondrion degradation (mitophagy). |
HAX1, BNIP3L, ACTL6A, SREBF1, CTSK, RPL28, SREBF2, ZBTB17, CTTN, PINK1, MAP1LC3B, ATP13A2, USP36, HDAC6, RUVBL1 |
GO:1903147 | BP | negative regulation of mitophagy | Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrion degradation (mitophagy). |
TSPO, PINK1 |
GO:1903169 | BP | regulation of calcium ion transmembrane transport | Any process that modulates the frequency, rate or extent of calcium ion transmembrane transport. |
TSPAN13, PIK3CG |
GO:1903170 | BP | negative regulation of calcium ion transmembrane transport | Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion transmembrane transport. |
ATP1A2 |
GO:1903202 | BP | negative regulation of oxidative stress-induced cell death | Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced cell death. |
PARK2, PINK1 |
GO:1903204 | BP | negative regulation of oxidative stress-induced neuron death | Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron death. |
ATF4, PINK1 |
GO:1903206 | BP | negative regulation of hydrogen peroxide-induced cell death | Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced cell death. |
GPR37, PSAP, TXN, NUP93 |
GO:1903208 | BP | negative regulation of hydrogen peroxide-induced neuron death | Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced neuron death. |
RACK1, NR4A3 |
GO:1903214 | BP | regulation of protein targeting to mitochondrion | Any process that modulates the frequency, rate or extent of protein targeting to mitochondrion. |
HAX1, BNIP3L, PARK2, SREBF1, PINK1 |
GO:1903225 | BP | negative regulation of endodermal cell differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of endodermal cell differentiation. |
COL5A2, COL5A1 |
GO:1903232 | BP | melanosome assembly | The aggregation, arrangement and bonding together of a set of components to form a melanosome, a tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. |
TRAPPC6A, RAB32, HPS1, HPS4 |
GO:1903233 | BP | regulation of calcium ion-dependent exocytosis of neurotransmitter | Any process that modulates the frequency, rate or extent of calcium ion-dependent exocytosis of neurotransmitter. |
ATP2A2, RAB3GAP1 |
GO:1903237 | BP | negative regulation of leukocyte tethering or rolling | Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte tethering or rolling. |
CXCL12 |
GO:1903238 | BP | positive regulation of leukocyte tethering or rolling | Any process that activates or increases the frequency, rate or extent of leukocyte tethering or rolling. |
PTAFR |
GO:1903242 | BP | regulation of cardiac muscle hypertrophy in response to stress | Any process that modulates the frequency, rate or extent of cardiac muscle hypertrophy in response to stress. |
BMP10 |
GO:1903243 | BP | negative regulation of cardiac muscle hypertrophy in response to stress | Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle hypertrophy in response to stress. |
ATP2B4, ERRFI1 |
GO:1903244 | BP | positive regulation of cardiac muscle hypertrophy in response to stress | Any process that activates or increases the frequency, rate or extent of cardiac muscle hypertrophy in response to stress. |
PPP3CA, TRPC3 |
GO:1903249 | BP | negative regulation of citrulline biosynthetic process | Any process that stops, prevents or reduces the frequency, rate or extent of citrulline biosynthetic process. |
ATP2B4 |
GO:1903262 | BP | negative regulation of serine phosphorylation of STAT3 protein | Any process that stops, prevents or reduces the frequency, rate or extent of serine phosphorylation of STAT3 protein. |
PWP1 |
GO:1903265 | BP | positive regulation of tumor necrosis factor-mediated signaling pathway | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor-mediated signaling pathway. |
PARK2, HSPA1A, HSPA1B |
GO:1903278 | BP | positive regulation of sodium ion export from cell | Any process that activates or increases the frequency, rate or extent of sodium ion export from cell. |
FXYD1, ATP1B1, ATP1B3 |
GO:1903280 | BP | negative regulation of calcium:sodium antiporter activity | Any process that stops, prevents or reduces the frequency, rate or extent of calcium:sodium antiporter activity. |
ATP1A2 |